Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management.

Orgiano L
;Pani F;Pusceddu V;Madeddu C;Massa E;CUBEDDU, ALESSIO;Demurtas L;PUSOLE, GRAZIA;Puzzoni M;Boi F;Mariotti S;Scartozzi M.
2016-01-01
2016
regorafenib
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie